Global Targeted Therapy Drugs for Cancer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Targeted Therapy Drugs for Cancer market size was valued at US$ 124495 million in 2025 and is forecast to a readjusted size of US$ 196419 million by 2032 with a CAGR of 7.1% during review period.
In 2025, global Targeted Therapy Drugs for Cancer reached approximately 58.76 M Units, with an average global market price of around 2059 USD per Unit.
Targeted therapy drugs for cancer are anticancer medicines designed to specifically interfere with molecular targets—such as mutated genes, abnormal proteins, or dysregulated signaling pathways—that drive the growth, survival, or spread of cancer cells. These targets are typically involved in processes like cell proliferation, angiogenesis, DNA repair, or immune evasion, and are more active or uniquely altered in cancer cells compared with normal cells.
Unlike traditional chemotherapy, which broadly affects rapidly dividing cells, targeted cancer therapies act in a more precise and mechanism-driven manner, aiming to block cancer-specific biological processes while minimizing damage to healthy tissues. They include small-molecule drugs (often taken orally and acting inside cells) and biologic agents such as monoclonal antibodies (usually acting on cell-surface targets or extracellular ligands). Targeted therapies are commonly selected based on biomarker or genetic testing, making them a central component of precision oncology.
The upstream raw materials for Targeted Therapy Drugs for Cancer mainly include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and excipients. Typical suppliers include Pfizer, Roche, Merck, and AstraZeneca. Downstream applications are primarily in oncology and rare disease treatments.
The single-line production capacity of Targeted Therapy Drugs for Cancer varies significantly depending on the drug molecule type, process complexity, equipment scale, and production mode. Industry gross margins typically range from 60% to 80%.
This report is a detailed and comprehensive analysis for global Targeted Therapy Drugs for Cancer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Targeted Therapy Drugs for Cancer market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs for Cancer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs for Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs for Cancer market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted Therapy Drugs for Cancer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted Therapy Drugs for Cancer market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Merck, Pfizer, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Bayer, GSK, Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Targeted Therapy Drugs for Cancer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Targeted Therapy Drugs for Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeted Therapy Drugs for Cancer, with price, sales quantity, revenue, and global market share of Targeted Therapy Drugs for Cancer from 2021 to 2026.
Chapter 3, the Targeted Therapy Drugs for Cancer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeted Therapy Drugs for Cancer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Targeted Therapy Drugs for Cancer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeted Therapy Drugs for Cancer.
Chapter 14 and 15, to describe Targeted Therapy Drugs for Cancer sales channel, distributors, customers, research findings and conclusion.
In 2025, global Targeted Therapy Drugs for Cancer reached approximately 58.76 M Units, with an average global market price of around 2059 USD per Unit.
Targeted therapy drugs for cancer are anticancer medicines designed to specifically interfere with molecular targets—such as mutated genes, abnormal proteins, or dysregulated signaling pathways—that drive the growth, survival, or spread of cancer cells. These targets are typically involved in processes like cell proliferation, angiogenesis, DNA repair, or immune evasion, and are more active or uniquely altered in cancer cells compared with normal cells.
Unlike traditional chemotherapy, which broadly affects rapidly dividing cells, targeted cancer therapies act in a more precise and mechanism-driven manner, aiming to block cancer-specific biological processes while minimizing damage to healthy tissues. They include small-molecule drugs (often taken orally and acting inside cells) and biologic agents such as monoclonal antibodies (usually acting on cell-surface targets or extracellular ligands). Targeted therapies are commonly selected based on biomarker or genetic testing, making them a central component of precision oncology.
The upstream raw materials for Targeted Therapy Drugs for Cancer mainly include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and excipients. Typical suppliers include Pfizer, Roche, Merck, and AstraZeneca. Downstream applications are primarily in oncology and rare disease treatments.
The single-line production capacity of Targeted Therapy Drugs for Cancer varies significantly depending on the drug molecule type, process complexity, equipment scale, and production mode. Industry gross margins typically range from 60% to 80%.
This report is a detailed and comprehensive analysis for global Targeted Therapy Drugs for Cancer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Targeted Therapy Drugs for Cancer market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs for Cancer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs for Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Targeted Therapy Drugs for Cancer market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted Therapy Drugs for Cancer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted Therapy Drugs for Cancer market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Merck, Pfizer, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Bayer, GSK, Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Targeted Therapy Drugs for Cancer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Kinase Inhibitors
- ADCs
- Others
- Oral Drugs
- Injectable Drugs
- Others
- Small Molecule Drugs
- Antibody Drugs
- Others
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Stomach Cancer
- Liver Cancer
- Others
- Roche
- Novartis
- Merck
- Pfizer
- AstraZeneca
- Johnson & Johnson
- Bristol Myers Squibb
- Bayer
- GSK
- Daiichi Sankyo
- Amgen
- Eli Lilly and Company
- AbbVie
- Sanofi
- Takeda
- Boehringer Ingelheim
- Beigene, Ltd.
- Jiangsu Hengrui Medicine
- INNOVENT BIOLOGICS(SUZHOU)
- Betta Pharmaceuticals
- Remegen Co.,Ltd.
- Shanghai Allist Pharmaceuticals
- Innocare
- Huiyu Pharmaceuticals
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Targeted Therapy Drugs for Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeted Therapy Drugs for Cancer, with price, sales quantity, revenue, and global market share of Targeted Therapy Drugs for Cancer from 2021 to 2026.
Chapter 3, the Targeted Therapy Drugs for Cancer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeted Therapy Drugs for Cancer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Targeted Therapy Drugs for Cancer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeted Therapy Drugs for Cancer.
Chapter 14 and 15, to describe Targeted Therapy Drugs for Cancer sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeted Therapy Drugs for Cancer Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Kinase Inhibitors
1.3.3 ADCs
1.3.4 Others
1.4 Market Analysis by Administration Route
1.4.1 Overview: Global Targeted Therapy Drugs for Cancer Consumption Value by Administration Route: 2021 Versus 2025 Versus 2032
1.4.2 Oral Drugs
1.4.3 Injectable Drugs
1.4.4 Others
1.5 Market Analysis by Molecular Properties
1.5.1 Overview: Global Targeted Therapy Drugs for Cancer Consumption Value by Molecular Properties: 2021 Versus 2025 Versus 2032
1.5.2 Small Molecule Drugs
1.5.3 Antibody Drugs
1.5.4 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Targeted Therapy Drugs for Cancer Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Lung Cancer
1.6.3 Breast Cancer
1.6.4 Colorectal Cancer
1.6.5 Stomach Cancer
1.6.6 Liver Cancer
1.6.7 Others
1.7 Global Targeted Therapy Drugs for Cancer Market Size & Forecast
1.7.1 Global Targeted Therapy Drugs for Cancer Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Targeted Therapy Drugs for Cancer Sales Quantity (2021-2032)
1.7.3 Global Targeted Therapy Drugs for Cancer Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Targeted Therapy Drugs for Cancer Product and Services
2.1.4 Roche Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Targeted Therapy Drugs for Cancer Product and Services
2.2.4 Novartis Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Novartis Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Targeted Therapy Drugs for Cancer Product and Services
2.3.4 Merck Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Targeted Therapy Drugs for Cancer Product and Services
2.4.4 Pfizer Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Pfizer Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Targeted Therapy Drugs for Cancer Product and Services
2.5.4 AstraZeneca Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Targeted Therapy Drugs for Cancer Product and Services
2.6.4 Johnson & Johnson Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Bristol Myers Squibb
2.7.1 Bristol Myers Squibb Details
2.7.2 Bristol Myers Squibb Major Business
2.7.3 Bristol Myers Squibb Targeted Therapy Drugs for Cancer Product and Services
2.7.4 Bristol Myers Squibb Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Bristol Myers Squibb Recent Developments/Updates
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Targeted Therapy Drugs for Cancer Product and Services
2.8.4 Bayer Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bayer Recent Developments/Updates
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Targeted Therapy Drugs for Cancer Product and Services
2.9.4 GSK Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 GSK Recent Developments/Updates
2.10 Daiichi Sankyo
2.10.1 Daiichi Sankyo Details
2.10.2 Daiichi Sankyo Major Business
2.10.3 Daiichi Sankyo Targeted Therapy Drugs for Cancer Product and Services
2.10.4 Daiichi Sankyo Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Daiichi Sankyo Recent Developments/Updates
2.11 Amgen
2.11.1 Amgen Details
2.11.2 Amgen Major Business
2.11.3 Amgen Targeted Therapy Drugs for Cancer Product and Services
2.11.4 Amgen Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Amgen Recent Developments/Updates
2.12 Eli Lilly and Company
2.12.1 Eli Lilly and Company Details
2.12.2 Eli Lilly and Company Major Business
2.12.3 Eli Lilly and Company Targeted Therapy Drugs for Cancer Product and Services
2.12.4 Eli Lilly and Company Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Eli Lilly and Company Recent Developments/Updates
2.13 AbbVie
2.13.1 AbbVie Details
2.13.2 AbbVie Major Business
2.13.3 AbbVie Targeted Therapy Drugs for Cancer Product and Services
2.13.4 AbbVie Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 AbbVie Recent Developments/Updates
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Targeted Therapy Drugs for Cancer Product and Services
2.14.4 Sanofi Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sanofi Recent Developments/Updates
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business
2.15.3 Takeda Targeted Therapy Drugs for Cancer Product and Services
2.15.4 Takeda Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Takeda Recent Developments/Updates
2.16 Boehringer Ingelheim
2.16.1 Boehringer Ingelheim Details
2.16.2 Boehringer Ingelheim Major Business
2.16.3 Boehringer Ingelheim Targeted Therapy Drugs for Cancer Product and Services
2.16.4 Boehringer Ingelheim Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Boehringer Ingelheim Recent Developments/Updates
2.17 Beigene, Ltd.
2.17.1 Beigene, Ltd. Details
2.17.2 Beigene, Ltd. Major Business
2.17.3 Beigene, Ltd. Targeted Therapy Drugs for Cancer Product and Services
2.17.4 Beigene, Ltd. Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Beigene, Ltd. Recent Developments/Updates
2.18 Jiangsu Hengrui Medicine
2.18.1 Jiangsu Hengrui Medicine Details
2.18.2 Jiangsu Hengrui Medicine Major Business
2.18.3 Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Product and Services
2.18.4 Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.19 INNOVENT BIOLOGICS(SUZHOU)
2.19.1 INNOVENT BIOLOGICS(SUZHOU) Details
2.19.2 INNOVENT BIOLOGICS(SUZHOU) Major Business
2.19.3 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Product and Services
2.19.4 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
2.20 Betta Pharmaceuticals
2.20.1 Betta Pharmaceuticals Details
2.20.2 Betta Pharmaceuticals Major Business
2.20.3 Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
2.20.4 Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Betta Pharmaceuticals Recent Developments/Updates
2.21 Remegen Co.,Ltd.
2.21.1 Remegen Co.,Ltd. Details
2.21.2 Remegen Co.,Ltd. Major Business
2.21.3 Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Product and Services
2.21.4 Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Remegen Co.,Ltd. Recent Developments/Updates
2.22 Shanghai Allist Pharmaceuticals
2.22.1 Shanghai Allist Pharmaceuticals Details
2.22.2 Shanghai Allist Pharmaceuticals Major Business
2.22.3 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
2.22.4 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
2.23 Innocare
2.23.1 Innocare Details
2.23.2 Innocare Major Business
2.23.3 Innocare Targeted Therapy Drugs for Cancer Product and Services
2.23.4 Innocare Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Innocare Recent Developments/Updates
2.24 Huiyu Pharmaceuticals
2.24.1 Huiyu Pharmaceuticals Details
2.24.2 Huiyu Pharmaceuticals Major Business
2.24.3 Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
2.24.4 Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Huiyu Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TARGETED THERAPY DRUGS FOR CANCER BY MANUFACTURER
3.1 Global Targeted Therapy Drugs for Cancer Sales Quantity by Manufacturer (2021-2026)
3.2 Global Targeted Therapy Drugs for Cancer Revenue by Manufacturer (2021-2026)
3.3 Global Targeted Therapy Drugs for Cancer Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Targeted Therapy Drugs for Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Targeted Therapy Drugs for Cancer Manufacturer Market Share in 2025
3.4.3 Top 6 Targeted Therapy Drugs for Cancer Manufacturer Market Share in 2025
3.5 Targeted Therapy Drugs for Cancer Market: Overall Company Footprint Analysis
3.5.1 Targeted Therapy Drugs for Cancer Market: Region Footprint
3.5.2 Targeted Therapy Drugs for Cancer Market: Company Product Type Footprint
3.5.3 Targeted Therapy Drugs for Cancer Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Targeted Therapy Drugs for Cancer Market Size by Region
4.1.1 Global Targeted Therapy Drugs for Cancer Sales Quantity by Region (2021-2032)
4.1.2 Global Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2032)
4.1.3 Global Targeted Therapy Drugs for Cancer Average Price by Region (2021-2032)
4.2 North America Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
4.3 Europe Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
4.4 Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
4.5 South America Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
4.6 Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
5.2 Global Targeted Therapy Drugs for Cancer Consumption Value by Type (2021-2032)
5.3 Global Targeted Therapy Drugs for Cancer Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
6.2 Global Targeted Therapy Drugs for Cancer Consumption Value by Application (2021-2032)
6.3 Global Targeted Therapy Drugs for Cancer Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
7.2 North America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
7.3 North America Targeted Therapy Drugs for Cancer Market Size by Country
7.3.1 North America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2032)
7.3.2 North America Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
8.2 Europe Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
8.3 Europe Targeted Therapy Drugs for Cancer Market Size by Country
8.3.1 Europe Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2032)
8.3.2 Europe Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Targeted Therapy Drugs for Cancer Market Size by Region
9.3.1 Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
10.2 South America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
10.3 South America Targeted Therapy Drugs for Cancer Market Size by Country
10.3.1 South America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2032)
10.3.2 South America Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Targeted Therapy Drugs for Cancer Market Size by Country
11.3.1 Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Targeted Therapy Drugs for Cancer Market Drivers
12.2 Targeted Therapy Drugs for Cancer Market Restraints
12.3 Targeted Therapy Drugs for Cancer Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Targeted Therapy Drugs for Cancer and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeted Therapy Drugs for Cancer
13.3 Targeted Therapy Drugs for Cancer Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeted Therapy Drugs for Cancer Typical Distributors
14.3 Targeted Therapy Drugs for Cancer Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeted Therapy Drugs for Cancer Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Kinase Inhibitors
1.3.3 ADCs
1.3.4 Others
1.4 Market Analysis by Administration Route
1.4.1 Overview: Global Targeted Therapy Drugs for Cancer Consumption Value by Administration Route: 2021 Versus 2025 Versus 2032
1.4.2 Oral Drugs
1.4.3 Injectable Drugs
1.4.4 Others
1.5 Market Analysis by Molecular Properties
1.5.1 Overview: Global Targeted Therapy Drugs for Cancer Consumption Value by Molecular Properties: 2021 Versus 2025 Versus 2032
1.5.2 Small Molecule Drugs
1.5.3 Antibody Drugs
1.5.4 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Targeted Therapy Drugs for Cancer Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Lung Cancer
1.6.3 Breast Cancer
1.6.4 Colorectal Cancer
1.6.5 Stomach Cancer
1.6.6 Liver Cancer
1.6.7 Others
1.7 Global Targeted Therapy Drugs for Cancer Market Size & Forecast
1.7.1 Global Targeted Therapy Drugs for Cancer Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Targeted Therapy Drugs for Cancer Sales Quantity (2021-2032)
1.7.3 Global Targeted Therapy Drugs for Cancer Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Targeted Therapy Drugs for Cancer Product and Services
2.1.4 Roche Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments/Updates
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Targeted Therapy Drugs for Cancer Product and Services
2.2.4 Novartis Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Novartis Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Targeted Therapy Drugs for Cancer Product and Services
2.3.4 Merck Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Targeted Therapy Drugs for Cancer Product and Services
2.4.4 Pfizer Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Pfizer Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Targeted Therapy Drugs for Cancer Product and Services
2.5.4 AstraZeneca Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Targeted Therapy Drugs for Cancer Product and Services
2.6.4 Johnson & Johnson Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Bristol Myers Squibb
2.7.1 Bristol Myers Squibb Details
2.7.2 Bristol Myers Squibb Major Business
2.7.3 Bristol Myers Squibb Targeted Therapy Drugs for Cancer Product and Services
2.7.4 Bristol Myers Squibb Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Bristol Myers Squibb Recent Developments/Updates
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Targeted Therapy Drugs for Cancer Product and Services
2.8.4 Bayer Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Bayer Recent Developments/Updates
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Targeted Therapy Drugs for Cancer Product and Services
2.9.4 GSK Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 GSK Recent Developments/Updates
2.10 Daiichi Sankyo
2.10.1 Daiichi Sankyo Details
2.10.2 Daiichi Sankyo Major Business
2.10.3 Daiichi Sankyo Targeted Therapy Drugs for Cancer Product and Services
2.10.4 Daiichi Sankyo Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Daiichi Sankyo Recent Developments/Updates
2.11 Amgen
2.11.1 Amgen Details
2.11.2 Amgen Major Business
2.11.3 Amgen Targeted Therapy Drugs for Cancer Product and Services
2.11.4 Amgen Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Amgen Recent Developments/Updates
2.12 Eli Lilly and Company
2.12.1 Eli Lilly and Company Details
2.12.2 Eli Lilly and Company Major Business
2.12.3 Eli Lilly and Company Targeted Therapy Drugs for Cancer Product and Services
2.12.4 Eli Lilly and Company Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Eli Lilly and Company Recent Developments/Updates
2.13 AbbVie
2.13.1 AbbVie Details
2.13.2 AbbVie Major Business
2.13.3 AbbVie Targeted Therapy Drugs for Cancer Product and Services
2.13.4 AbbVie Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 AbbVie Recent Developments/Updates
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Targeted Therapy Drugs for Cancer Product and Services
2.14.4 Sanofi Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Sanofi Recent Developments/Updates
2.15 Takeda
2.15.1 Takeda Details
2.15.2 Takeda Major Business
2.15.3 Takeda Targeted Therapy Drugs for Cancer Product and Services
2.15.4 Takeda Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Takeda Recent Developments/Updates
2.16 Boehringer Ingelheim
2.16.1 Boehringer Ingelheim Details
2.16.2 Boehringer Ingelheim Major Business
2.16.3 Boehringer Ingelheim Targeted Therapy Drugs for Cancer Product and Services
2.16.4 Boehringer Ingelheim Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Boehringer Ingelheim Recent Developments/Updates
2.17 Beigene, Ltd.
2.17.1 Beigene, Ltd. Details
2.17.2 Beigene, Ltd. Major Business
2.17.3 Beigene, Ltd. Targeted Therapy Drugs for Cancer Product and Services
2.17.4 Beigene, Ltd. Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Beigene, Ltd. Recent Developments/Updates
2.18 Jiangsu Hengrui Medicine
2.18.1 Jiangsu Hengrui Medicine Details
2.18.2 Jiangsu Hengrui Medicine Major Business
2.18.3 Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Product and Services
2.18.4 Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.19 INNOVENT BIOLOGICS(SUZHOU)
2.19.1 INNOVENT BIOLOGICS(SUZHOU) Details
2.19.2 INNOVENT BIOLOGICS(SUZHOU) Major Business
2.19.3 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Product and Services
2.19.4 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
2.20 Betta Pharmaceuticals
2.20.1 Betta Pharmaceuticals Details
2.20.2 Betta Pharmaceuticals Major Business
2.20.3 Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
2.20.4 Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Betta Pharmaceuticals Recent Developments/Updates
2.21 Remegen Co.,Ltd.
2.21.1 Remegen Co.,Ltd. Details
2.21.2 Remegen Co.,Ltd. Major Business
2.21.3 Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Product and Services
2.21.4 Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Remegen Co.,Ltd. Recent Developments/Updates
2.22 Shanghai Allist Pharmaceuticals
2.22.1 Shanghai Allist Pharmaceuticals Details
2.22.2 Shanghai Allist Pharmaceuticals Major Business
2.22.3 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
2.22.4 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
2.23 Innocare
2.23.1 Innocare Details
2.23.2 Innocare Major Business
2.23.3 Innocare Targeted Therapy Drugs for Cancer Product and Services
2.23.4 Innocare Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Innocare Recent Developments/Updates
2.24 Huiyu Pharmaceuticals
2.24.1 Huiyu Pharmaceuticals Details
2.24.2 Huiyu Pharmaceuticals Major Business
2.24.3 Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
2.24.4 Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Huiyu Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TARGETED THERAPY DRUGS FOR CANCER BY MANUFACTURER
3.1 Global Targeted Therapy Drugs for Cancer Sales Quantity by Manufacturer (2021-2026)
3.2 Global Targeted Therapy Drugs for Cancer Revenue by Manufacturer (2021-2026)
3.3 Global Targeted Therapy Drugs for Cancer Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Targeted Therapy Drugs for Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Targeted Therapy Drugs for Cancer Manufacturer Market Share in 2025
3.4.3 Top 6 Targeted Therapy Drugs for Cancer Manufacturer Market Share in 2025
3.5 Targeted Therapy Drugs for Cancer Market: Overall Company Footprint Analysis
3.5.1 Targeted Therapy Drugs for Cancer Market: Region Footprint
3.5.2 Targeted Therapy Drugs for Cancer Market: Company Product Type Footprint
3.5.3 Targeted Therapy Drugs for Cancer Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Targeted Therapy Drugs for Cancer Market Size by Region
4.1.1 Global Targeted Therapy Drugs for Cancer Sales Quantity by Region (2021-2032)
4.1.2 Global Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2032)
4.1.3 Global Targeted Therapy Drugs for Cancer Average Price by Region (2021-2032)
4.2 North America Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
4.3 Europe Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
4.4 Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
4.5 South America Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
4.6 Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
5.2 Global Targeted Therapy Drugs for Cancer Consumption Value by Type (2021-2032)
5.3 Global Targeted Therapy Drugs for Cancer Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
6.2 Global Targeted Therapy Drugs for Cancer Consumption Value by Application (2021-2032)
6.3 Global Targeted Therapy Drugs for Cancer Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
7.2 North America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
7.3 North America Targeted Therapy Drugs for Cancer Market Size by Country
7.3.1 North America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2032)
7.3.2 North America Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
8.2 Europe Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
8.3 Europe Targeted Therapy Drugs for Cancer Market Size by Country
8.3.1 Europe Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2032)
8.3.2 Europe Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Targeted Therapy Drugs for Cancer Market Size by Region
9.3.1 Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
10.2 South America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
10.3 South America Targeted Therapy Drugs for Cancer Market Size by Country
10.3.1 South America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2032)
10.3.2 South America Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Targeted Therapy Drugs for Cancer Market Size by Country
11.3.1 Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Targeted Therapy Drugs for Cancer Market Drivers
12.2 Targeted Therapy Drugs for Cancer Market Restraints
12.3 Targeted Therapy Drugs for Cancer Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Targeted Therapy Drugs for Cancer and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeted Therapy Drugs for Cancer
13.3 Targeted Therapy Drugs for Cancer Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeted Therapy Drugs for Cancer Typical Distributors
14.3 Targeted Therapy Drugs for Cancer Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Targeted Therapy Drugs for Cancer Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Targeted Therapy Drugs for Cancer Consumption Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 3. Global Targeted Therapy Drugs for Cancer Consumption Value by Molecular Properties, (USD Million), 2021 & 2025 & 2032
Table 4. Global Targeted Therapy Drugs for Cancer Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Roche Basic Information, Manufacturing Base and Competitors
Table 6. Roche Major Business
Table 7. Roche Targeted Therapy Drugs for Cancer Product and Services
Table 8. Roche Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Roche Recent Developments/Updates
Table 10. Novartis Basic Information, Manufacturing Base and Competitors
Table 11. Novartis Major Business
Table 12. Novartis Targeted Therapy Drugs for Cancer Product and Services
Table 13. Novartis Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Novartis Recent Developments/Updates
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Targeted Therapy Drugs for Cancer Product and Services
Table 18. Merck Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Merck Recent Developments/Updates
Table 20. Pfizer Basic Information, Manufacturing Base and Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Targeted Therapy Drugs for Cancer Product and Services
Table 23. Pfizer Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Pfizer Recent Developments/Updates
Table 25. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca Major Business
Table 27. AstraZeneca Targeted Therapy Drugs for Cancer Product and Services
Table 28. AstraZeneca Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. AstraZeneca Recent Developments/Updates
Table 30. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Targeted Therapy Drugs for Cancer Product and Services
Table 33. Johnson & Johnson Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Johnson & Johnson Recent Developments/Updates
Table 35. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 36. Bristol Myers Squibb Major Business
Table 37. Bristol Myers Squibb Targeted Therapy Drugs for Cancer Product and Services
Table 38. Bristol Myers Squibb Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Bristol Myers Squibb Recent Developments/Updates
Table 40. Bayer Basic Information, Manufacturing Base and Competitors
Table 41. Bayer Major Business
Table 42. Bayer Targeted Therapy Drugs for Cancer Product and Services
Table 43. Bayer Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Bayer Recent Developments/Updates
Table 45. GSK Basic Information, Manufacturing Base and Competitors
Table 46. GSK Major Business
Table 47. GSK Targeted Therapy Drugs for Cancer Product and Services
Table 48. GSK Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. GSK Recent Developments/Updates
Table 50. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 51. Daiichi Sankyo Major Business
Table 52. Daiichi Sankyo Targeted Therapy Drugs for Cancer Product and Services
Table 53. Daiichi Sankyo Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Daiichi Sankyo Recent Developments/Updates
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Major Business
Table 57. Amgen Targeted Therapy Drugs for Cancer Product and Services
Table 58. Amgen Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Amgen Recent Developments/Updates
Table 60. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 61. Eli Lilly and Company Major Business
Table 62. Eli Lilly and Company Targeted Therapy Drugs for Cancer Product and Services
Table 63. Eli Lilly and Company Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Eli Lilly and Company Recent Developments/Updates
Table 65. AbbVie Basic Information, Manufacturing Base and Competitors
Table 66. AbbVie Major Business
Table 67. AbbVie Targeted Therapy Drugs for Cancer Product and Services
Table 68. AbbVie Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. AbbVie Recent Developments/Updates
Table 70. Sanofi Basic Information, Manufacturing Base and Competitors
Table 71. Sanofi Major Business
Table 72. Sanofi Targeted Therapy Drugs for Cancer Product and Services
Table 73. Sanofi Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Sanofi Recent Developments/Updates
Table 75. Takeda Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Major Business
Table 77. Takeda Targeted Therapy Drugs for Cancer Product and Services
Table 78. Takeda Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Takeda Recent Developments/Updates
Table 80. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 81. Boehringer Ingelheim Major Business
Table 82. Boehringer Ingelheim Targeted Therapy Drugs for Cancer Product and Services
Table 83. Boehringer Ingelheim Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Beigene, Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Beigene, Ltd. Major Business
Table 87. Beigene, Ltd. Targeted Therapy Drugs for Cancer Product and Services
Table 88. Beigene, Ltd. Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Beigene, Ltd. Recent Developments/Updates
Table 90. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 91. Jiangsu Hengrui Medicine Major Business
Table 92. Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Product and Services
Table 93. Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 95. INNOVENT BIOLOGICS(SUZHOU) Basic Information, Manufacturing Base and Competitors
Table 96. INNOVENT BIOLOGICS(SUZHOU) Major Business
Table 97. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Product and Services
Table 98. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
Table 100. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 101. Betta Pharmaceuticals Major Business
Table 102. Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
Table 103. Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Betta Pharmaceuticals Recent Developments/Updates
Table 105. Remegen Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 106. Remegen Co.,Ltd. Major Business
Table 107. Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Product and Services
Table 108. Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Remegen Co.,Ltd. Recent Developments/Updates
Table 110. Shanghai Allist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 111. Shanghai Allist Pharmaceuticals Major Business
Table 112. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
Table 113. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Shanghai Allist Pharmaceuticals Recent Developments/Updates
Table 115. Innocare Basic Information, Manufacturing Base and Competitors
Table 116. Innocare Major Business
Table 117. Innocare Targeted Therapy Drugs for Cancer Product and Services
Table 118. Innocare Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Innocare Recent Developments/Updates
Table 120. Huiyu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 121. Huiyu Pharmaceuticals Major Business
Table 122. Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
Table 123. Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 124. Huiyu Pharmaceuticals Recent Developments/Updates
Table 125. Global Targeted Therapy Drugs for Cancer Sales Quantity by Manufacturer (2021-2026) & (M Units)
Table 126. Global Targeted Therapy Drugs for Cancer Revenue by Manufacturer (2021-2026) & (USD Million)
Table 127. Global Targeted Therapy Drugs for Cancer Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 128. Market Position of Manufacturers in Targeted Therapy Drugs for Cancer, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 129. Head Office and Targeted Therapy Drugs for Cancer Production Site of Key Manufacturer
Table 130. Targeted Therapy Drugs for Cancer Market: Company Product Type Footprint
Table 131. Targeted Therapy Drugs for Cancer Market: Company Product Application Footprint
Table 132. Targeted Therapy Drugs for Cancer New Market Entrants and Barriers to Market Entry
Table 133. Targeted Therapy Drugs for Cancer Mergers, Acquisition, Agreements, and Collaborations
Table 134. Global Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 135. Global Targeted Therapy Drugs for Cancer Sales Quantity by Region (2021-2026) & (M Units)
Table 136. Global Targeted Therapy Drugs for Cancer Sales Quantity by Region (2027-2032) & (M Units)
Table 137. Global Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 138. Global Targeted Therapy Drugs for Cancer Consumption Value by Region (2027-2032) & (USD Million)
Table 139. Global Targeted Therapy Drugs for Cancer Average Price by Region (2021-2026) & (US$/Unit)
Table 140. Global Targeted Therapy Drugs for Cancer Average Price by Region (2027-2032) & (US$/Unit)
Table 141. Global Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 142. Global Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 143. Global Targeted Therapy Drugs for Cancer Consumption Value by Type (2021-2026) & (USD Million)
Table 144. Global Targeted Therapy Drugs for Cancer Consumption Value by Type (2027-2032) & (USD Million)
Table 145. Global Targeted Therapy Drugs for Cancer Average Price by Type (2021-2026) & (US$/Unit)
Table 146. Global Targeted Therapy Drugs for Cancer Average Price by Type (2027-2032) & (US$/Unit)
Table 147. Global Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 148. Global Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 149. Global Targeted Therapy Drugs for Cancer Consumption Value by Application (2021-2026) & (USD Million)
Table 150. Global Targeted Therapy Drugs for Cancer Consumption Value by Application (2027-2032) & (USD Million)
Table 151. Global Targeted Therapy Drugs for Cancer Average Price by Application (2021-2026) & (US$/Unit)
Table 152. Global Targeted Therapy Drugs for Cancer Average Price by Application (2027-2032) & (US$/Unit)
Table 153. North America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 154. North America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 155. North America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 156. North America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 157. North America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2026) & (M Units)
Table 158. North America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2027-2032) & (M Units)
Table 159. North America Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 160. North America Targeted Therapy Drugs for Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 162. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 163. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 164. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 165. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2026) & (M Units)
Table 166. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Country (2027-2032) & (M Units)
Table 167. Europe Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 168. Europe Targeted Therapy Drugs for Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 169. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 170. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 171. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 172. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 173. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Region (2021-2026) & (M Units)
Table 174. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Region (2027-2032) & (M Units)
Table 175. Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 176. Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value by Region (2027-2032) & (USD Million)
Table 177. South America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 178. South America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 179. South America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 180. South America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 181. South America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2026) & (M Units)
Table 182. South America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2027-2032) & (M Units)
Table 183. South America Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 184. South America Targeted Therapy Drugs for Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 185. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 186. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 187. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 188. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 189. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2026) & (M Units)
Table 190. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Country (2027-2032) & (M Units)
Table 191. Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 192. Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 193. Targeted Therapy Drugs for Cancer Raw Material
Table 194. Key Manufacturers of Targeted Therapy Drugs for Cancer Raw Materials
Table 195. Targeted Therapy Drugs for Cancer Typical Distributors
Table 196. Targeted Therapy Drugs for Cancer Typical Customers
Table 1. Global Targeted Therapy Drugs for Cancer Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Targeted Therapy Drugs for Cancer Consumption Value by Administration Route, (USD Million), 2021 & 2025 & 2032
Table 3. Global Targeted Therapy Drugs for Cancer Consumption Value by Molecular Properties, (USD Million), 2021 & 2025 & 2032
Table 4. Global Targeted Therapy Drugs for Cancer Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Roche Basic Information, Manufacturing Base and Competitors
Table 6. Roche Major Business
Table 7. Roche Targeted Therapy Drugs for Cancer Product and Services
Table 8. Roche Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Roche Recent Developments/Updates
Table 10. Novartis Basic Information, Manufacturing Base and Competitors
Table 11. Novartis Major Business
Table 12. Novartis Targeted Therapy Drugs for Cancer Product and Services
Table 13. Novartis Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Novartis Recent Developments/Updates
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Targeted Therapy Drugs for Cancer Product and Services
Table 18. Merck Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Merck Recent Developments/Updates
Table 20. Pfizer Basic Information, Manufacturing Base and Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Targeted Therapy Drugs for Cancer Product and Services
Table 23. Pfizer Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Pfizer Recent Developments/Updates
Table 25. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca Major Business
Table 27. AstraZeneca Targeted Therapy Drugs for Cancer Product and Services
Table 28. AstraZeneca Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. AstraZeneca Recent Developments/Updates
Table 30. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Targeted Therapy Drugs for Cancer Product and Services
Table 33. Johnson & Johnson Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Johnson & Johnson Recent Developments/Updates
Table 35. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 36. Bristol Myers Squibb Major Business
Table 37. Bristol Myers Squibb Targeted Therapy Drugs for Cancer Product and Services
Table 38. Bristol Myers Squibb Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Bristol Myers Squibb Recent Developments/Updates
Table 40. Bayer Basic Information, Manufacturing Base and Competitors
Table 41. Bayer Major Business
Table 42. Bayer Targeted Therapy Drugs for Cancer Product and Services
Table 43. Bayer Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Bayer Recent Developments/Updates
Table 45. GSK Basic Information, Manufacturing Base and Competitors
Table 46. GSK Major Business
Table 47. GSK Targeted Therapy Drugs for Cancer Product and Services
Table 48. GSK Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. GSK Recent Developments/Updates
Table 50. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 51. Daiichi Sankyo Major Business
Table 52. Daiichi Sankyo Targeted Therapy Drugs for Cancer Product and Services
Table 53. Daiichi Sankyo Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Daiichi Sankyo Recent Developments/Updates
Table 55. Amgen Basic Information, Manufacturing Base and Competitors
Table 56. Amgen Major Business
Table 57. Amgen Targeted Therapy Drugs for Cancer Product and Services
Table 58. Amgen Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Amgen Recent Developments/Updates
Table 60. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 61. Eli Lilly and Company Major Business
Table 62. Eli Lilly and Company Targeted Therapy Drugs for Cancer Product and Services
Table 63. Eli Lilly and Company Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Eli Lilly and Company Recent Developments/Updates
Table 65. AbbVie Basic Information, Manufacturing Base and Competitors
Table 66. AbbVie Major Business
Table 67. AbbVie Targeted Therapy Drugs for Cancer Product and Services
Table 68. AbbVie Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. AbbVie Recent Developments/Updates
Table 70. Sanofi Basic Information, Manufacturing Base and Competitors
Table 71. Sanofi Major Business
Table 72. Sanofi Targeted Therapy Drugs for Cancer Product and Services
Table 73. Sanofi Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Sanofi Recent Developments/Updates
Table 75. Takeda Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Major Business
Table 77. Takeda Targeted Therapy Drugs for Cancer Product and Services
Table 78. Takeda Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Takeda Recent Developments/Updates
Table 80. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 81. Boehringer Ingelheim Major Business
Table 82. Boehringer Ingelheim Targeted Therapy Drugs for Cancer Product and Services
Table 83. Boehringer Ingelheim Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Beigene, Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Beigene, Ltd. Major Business
Table 87. Beigene, Ltd. Targeted Therapy Drugs for Cancer Product and Services
Table 88. Beigene, Ltd. Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Beigene, Ltd. Recent Developments/Updates
Table 90. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 91. Jiangsu Hengrui Medicine Major Business
Table 92. Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Product and Services
Table 93. Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 95. INNOVENT BIOLOGICS(SUZHOU) Basic Information, Manufacturing Base and Competitors
Table 96. INNOVENT BIOLOGICS(SUZHOU) Major Business
Table 97. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Product and Services
Table 98. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
Table 100. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 101. Betta Pharmaceuticals Major Business
Table 102. Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
Table 103. Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Betta Pharmaceuticals Recent Developments/Updates
Table 105. Remegen Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 106. Remegen Co.,Ltd. Major Business
Table 107. Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Product and Services
Table 108. Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Remegen Co.,Ltd. Recent Developments/Updates
Table 110. Shanghai Allist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 111. Shanghai Allist Pharmaceuticals Major Business
Table 112. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
Table 113. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Shanghai Allist Pharmaceuticals Recent Developments/Updates
Table 115. Innocare Basic Information, Manufacturing Base and Competitors
Table 116. Innocare Major Business
Table 117. Innocare Targeted Therapy Drugs for Cancer Product and Services
Table 118. Innocare Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Innocare Recent Developments/Updates
Table 120. Huiyu Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 121. Huiyu Pharmaceuticals Major Business
Table 122. Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Product and Services
Table 123. Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 124. Huiyu Pharmaceuticals Recent Developments/Updates
Table 125. Global Targeted Therapy Drugs for Cancer Sales Quantity by Manufacturer (2021-2026) & (M Units)
Table 126. Global Targeted Therapy Drugs for Cancer Revenue by Manufacturer (2021-2026) & (USD Million)
Table 127. Global Targeted Therapy Drugs for Cancer Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 128. Market Position of Manufacturers in Targeted Therapy Drugs for Cancer, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 129. Head Office and Targeted Therapy Drugs for Cancer Production Site of Key Manufacturer
Table 130. Targeted Therapy Drugs for Cancer Market: Company Product Type Footprint
Table 131. Targeted Therapy Drugs for Cancer Market: Company Product Application Footprint
Table 132. Targeted Therapy Drugs for Cancer New Market Entrants and Barriers to Market Entry
Table 133. Targeted Therapy Drugs for Cancer Mergers, Acquisition, Agreements, and Collaborations
Table 134. Global Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 135. Global Targeted Therapy Drugs for Cancer Sales Quantity by Region (2021-2026) & (M Units)
Table 136. Global Targeted Therapy Drugs for Cancer Sales Quantity by Region (2027-2032) & (M Units)
Table 137. Global Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 138. Global Targeted Therapy Drugs for Cancer Consumption Value by Region (2027-2032) & (USD Million)
Table 139. Global Targeted Therapy Drugs for Cancer Average Price by Region (2021-2026) & (US$/Unit)
Table 140. Global Targeted Therapy Drugs for Cancer Average Price by Region (2027-2032) & (US$/Unit)
Table 141. Global Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 142. Global Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 143. Global Targeted Therapy Drugs for Cancer Consumption Value by Type (2021-2026) & (USD Million)
Table 144. Global Targeted Therapy Drugs for Cancer Consumption Value by Type (2027-2032) & (USD Million)
Table 145. Global Targeted Therapy Drugs for Cancer Average Price by Type (2021-2026) & (US$/Unit)
Table 146. Global Targeted Therapy Drugs for Cancer Average Price by Type (2027-2032) & (US$/Unit)
Table 147. Global Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 148. Global Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 149. Global Targeted Therapy Drugs for Cancer Consumption Value by Application (2021-2026) & (USD Million)
Table 150. Global Targeted Therapy Drugs for Cancer Consumption Value by Application (2027-2032) & (USD Million)
Table 151. Global Targeted Therapy Drugs for Cancer Average Price by Application (2021-2026) & (US$/Unit)
Table 152. Global Targeted Therapy Drugs for Cancer Average Price by Application (2027-2032) & (US$/Unit)
Table 153. North America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 154. North America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 155. North America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 156. North America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 157. North America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2026) & (M Units)
Table 158. North America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2027-2032) & (M Units)
Table 159. North America Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 160. North America Targeted Therapy Drugs for Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 161. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 162. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 163. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 164. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 165. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2026) & (M Units)
Table 166. Europe Targeted Therapy Drugs for Cancer Sales Quantity by Country (2027-2032) & (M Units)
Table 167. Europe Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 168. Europe Targeted Therapy Drugs for Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 169. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 170. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 171. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 172. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 173. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Region (2021-2026) & (M Units)
Table 174. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity by Region (2027-2032) & (M Units)
Table 175. Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 176. Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value by Region (2027-2032) & (USD Million)
Table 177. South America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 178. South America Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 179. South America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 180. South America Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 181. South America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2026) & (M Units)
Table 182. South America Targeted Therapy Drugs for Cancer Sales Quantity by Country (2027-2032) & (M Units)
Table 183. South America Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 184. South America Targeted Therapy Drugs for Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 185. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Type (2021-2026) & (M Units)
Table 186. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Type (2027-2032) & (M Units)
Table 187. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Application (2021-2026) & (M Units)
Table 188. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Application (2027-2032) & (M Units)
Table 189. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Country (2021-2026) & (M Units)
Table 190. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity by Country (2027-2032) & (M Units)
Table 191. Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 192. Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 193. Targeted Therapy Drugs for Cancer Raw Material
Table 194. Key Manufacturers of Targeted Therapy Drugs for Cancer Raw Materials
Table 195. Targeted Therapy Drugs for Cancer Typical Distributors
Table 196. Targeted Therapy Drugs for Cancer Typical Customers
LIST OF FIGURES
Figure 1. Targeted Therapy Drugs for Cancer Picture
Figure 2. Global Targeted Therapy Drugs for Cancer Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Type in 2025
Figure 4. Kinase Inhibitors Examples
Figure 5. ADCs Examples
Figure 6. Others Examples
Figure 7. Global Targeted Therapy Drugs for Cancer Revenue by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Administration Route in 2025
Figure 9. Oral Drugs Examples
Figure 10. Injectable Drugs Examples
Figure 11. Others Examples
Figure 12. Global Targeted Therapy Drugs for Cancer Revenue by Molecular Properties, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Molecular Properties in 2025
Figure 14. Small Molecule Drugs Examples
Figure 15. Antibody Drugs Examples
Figure 16. Others Examples
Figure 17. Global Targeted Therapy Drugs for Cancer Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Application in 2025
Figure 19. Lung Cancer Examples
Figure 20. Breast Cancer Examples
Figure 21. Colorectal Cancer Examples
Figure 22. Stomach Cancer Examples
Figure 23. Liver Cancer Examples
Figure 24. Others Examples
Figure 25. Global Targeted Therapy Drugs for Cancer Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Targeted Therapy Drugs for Cancer Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Targeted Therapy Drugs for Cancer Sales Quantity (2021-2032) & (M Units)
Figure 28. Global Targeted Therapy Drugs for Cancer Price (2021-2032) & (US$/Unit)
Figure 29. Global Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Manufacturer in 2025
Figure 30. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Manufacturer in 2025
Figure 31. Producer Shipments of Targeted Therapy Drugs for Cancer by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 32. Top 3 Targeted Therapy Drugs for Cancer Manufacturer (Revenue) Market Share in 2025
Figure 33. Top 6 Targeted Therapy Drugs for Cancer Manufacturer (Revenue) Market Share in 2025
Figure 34. Global Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Region (2021-2032)
Figure 35. Global Targeted Therapy Drugs for Cancer Consumption Value Market Share by Region (2021-2032)
Figure 36. North America Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 38. Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 39. South America Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 40. Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 41. Global Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 42. Global Targeted Therapy Drugs for Cancer Consumption Value Market Share by Type (2021-2032)
Figure 43. Global Targeted Therapy Drugs for Cancer Average Price by Type (2021-2032) & (US$/Unit)
Figure 44. Global Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 45. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Application (2021-2032)
Figure 46. Global Targeted Therapy Drugs for Cancer Average Price by Application (2021-2032) & (US$/Unit)
Figure 47. North America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 48. North America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 49. North America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 50. North America Targeted Therapy Drugs for Cancer Consumption Value Market Share by Country (2021-2032)
Figure 51. United States Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 52. Canada Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 53. Mexico Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 54. Europe Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 55. Europe Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 56. Europe Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 57. Europe Targeted Therapy Drugs for Cancer Consumption Value Market Share by Country (2021-2032)
Figure 58. Germany Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 59. France Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 60. United Kingdom Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 61. Russia Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 62. Italy Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 63. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 64. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 65. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Region (2021-2032)
Figure 66. Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value Market Share by Region (2021-2032)
Figure 67. China Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 68. Japan Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 69. South Korea Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 70. India Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 71. Southeast Asia Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 72. Australia Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 73. South America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 74. South America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 75. South America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 76. South America Targeted Therapy Drugs for Cancer Consumption Value Market Share by Country (2021-2032)
Figure 77. Brazil Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 78. Argentina Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 79. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 80. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 81. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 82. Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value Market Share by Country (2021-2032)
Figure 83. Turkey Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 84. Egypt Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 85. Saudi Arabia Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 86. South Africa Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 87. Targeted Therapy Drugs for Cancer Market Drivers
Figure 88. Targeted Therapy Drugs for Cancer Market Restraints
Figure 89. Targeted Therapy Drugs for Cancer Market Trends
Figure 90. Porters Five Forces Analysis
Figure 91. Manufacturing Cost Structure Analysis of Targeted Therapy Drugs for Cancer in 2025
Figure 92. Manufacturing Process Analysis of Targeted Therapy Drugs for Cancer
Figure 93. Targeted Therapy Drugs for Cancer Industrial Chain
Figure 94. Sales Channel: Direct to End-User vs Distributors
Figure 95. Direct Channel Pros & Cons
Figure 96. Indirect Channel Pros & Cons
Figure 97. Methodology
Figure 98. Research Process and Data Source
Figure 1. Targeted Therapy Drugs for Cancer Picture
Figure 2. Global Targeted Therapy Drugs for Cancer Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Type in 2025
Figure 4. Kinase Inhibitors Examples
Figure 5. ADCs Examples
Figure 6. Others Examples
Figure 7. Global Targeted Therapy Drugs for Cancer Revenue by Administration Route, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Administration Route in 2025
Figure 9. Oral Drugs Examples
Figure 10. Injectable Drugs Examples
Figure 11. Others Examples
Figure 12. Global Targeted Therapy Drugs for Cancer Revenue by Molecular Properties, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Molecular Properties in 2025
Figure 14. Small Molecule Drugs Examples
Figure 15. Antibody Drugs Examples
Figure 16. Others Examples
Figure 17. Global Targeted Therapy Drugs for Cancer Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Application in 2025
Figure 19. Lung Cancer Examples
Figure 20. Breast Cancer Examples
Figure 21. Colorectal Cancer Examples
Figure 22. Stomach Cancer Examples
Figure 23. Liver Cancer Examples
Figure 24. Others Examples
Figure 25. Global Targeted Therapy Drugs for Cancer Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 26. Global Targeted Therapy Drugs for Cancer Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 27. Global Targeted Therapy Drugs for Cancer Sales Quantity (2021-2032) & (M Units)
Figure 28. Global Targeted Therapy Drugs for Cancer Price (2021-2032) & (US$/Unit)
Figure 29. Global Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Manufacturer in 2025
Figure 30. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Manufacturer in 2025
Figure 31. Producer Shipments of Targeted Therapy Drugs for Cancer by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 32. Top 3 Targeted Therapy Drugs for Cancer Manufacturer (Revenue) Market Share in 2025
Figure 33. Top 6 Targeted Therapy Drugs for Cancer Manufacturer (Revenue) Market Share in 2025
Figure 34. Global Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Region (2021-2032)
Figure 35. Global Targeted Therapy Drugs for Cancer Consumption Value Market Share by Region (2021-2032)
Figure 36. North America Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 38. Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 39. South America Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 40. Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 41. Global Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 42. Global Targeted Therapy Drugs for Cancer Consumption Value Market Share by Type (2021-2032)
Figure 43. Global Targeted Therapy Drugs for Cancer Average Price by Type (2021-2032) & (US$/Unit)
Figure 44. Global Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 45. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Application (2021-2032)
Figure 46. Global Targeted Therapy Drugs for Cancer Average Price by Application (2021-2032) & (US$/Unit)
Figure 47. North America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 48. North America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 49. North America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 50. North America Targeted Therapy Drugs for Cancer Consumption Value Market Share by Country (2021-2032)
Figure 51. United States Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 52. Canada Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 53. Mexico Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 54. Europe Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 55. Europe Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 56. Europe Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 57. Europe Targeted Therapy Drugs for Cancer Consumption Value Market Share by Country (2021-2032)
Figure 58. Germany Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 59. France Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 60. United Kingdom Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 61. Russia Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 62. Italy Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 63. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 64. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 65. Asia-Pacific Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Region (2021-2032)
Figure 66. Asia-Pacific Targeted Therapy Drugs for Cancer Consumption Value Market Share by Region (2021-2032)
Figure 67. China Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 68. Japan Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 69. South Korea Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 70. India Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 71. Southeast Asia Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 72. Australia Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 73. South America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 74. South America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 75. South America Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 76. South America Targeted Therapy Drugs for Cancer Consumption Value Market Share by Country (2021-2032)
Figure 77. Brazil Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 78. Argentina Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 79. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 80. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 81. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 82. Middle East & Africa Targeted Therapy Drugs for Cancer Consumption Value Market Share by Country (2021-2032)
Figure 83. Turkey Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 84. Egypt Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 85. Saudi Arabia Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 86. South Africa Targeted Therapy Drugs for Cancer Consumption Value (2021-2032) & (USD Million)
Figure 87. Targeted Therapy Drugs for Cancer Market Drivers
Figure 88. Targeted Therapy Drugs for Cancer Market Restraints
Figure 89. Targeted Therapy Drugs for Cancer Market Trends
Figure 90. Porters Five Forces Analysis
Figure 91. Manufacturing Cost Structure Analysis of Targeted Therapy Drugs for Cancer in 2025
Figure 92. Manufacturing Process Analysis of Targeted Therapy Drugs for Cancer
Figure 93. Targeted Therapy Drugs for Cancer Industrial Chain
Figure 94. Sales Channel: Direct to End-User vs Distributors
Figure 95. Direct Channel Pros & Cons
Figure 96. Indirect Channel Pros & Cons
Figure 97. Methodology
Figure 98. Research Process and Data Source
